The 20 Best Pulmonary Fibrosis Doctors Near Me in Glen Burnie, MD

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Endoscopy. Dr. Danoff is board certified in American Board Of Internal Medicine.

Maureen Horton is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Horton is rated as an Elite provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

. Dr. Davidson is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His clinical expertise encompasses Pulmonary Fibrosis, Pneumonia, Lung Metastases, and Parapneumonic Pleural Effusion. Dr. Davidson is board certified in American Board Of Internal Medicine.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Lung Metastases, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shortening were first identified in the context of dyskeratosis congenita, a premature aging syndrome that predisposes to cancer. Dyskeratosis congenita patients and patients with telomere-mediated syndromes have an increased risk for developing certain malignancies which include myelodysplastic syndromes, myeloid leukemia and squamous cell carcinomas of the upper aerodigestive tract. The Telomere Clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides multi-disciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include individuals with cancer, bone marrow failure/aplastic anemia, lung disease including idiopathic pulmonary fibrosis and liver cirrhosis, among others. Our clinic brings together geneticists, genetic counselors, and we work closely with expert physicians in adult and pediatric hematology, bone marrow transplant, pulmonary medicine, lung transplant medicine, hepatology, and otolaryngology. Together, our team has established expertise in the management of these disorders and is at the forefront of leading the effort to individualize care for affected patients and their families. My group also has ongoing research efforts which include a long-term study to understand the genetics and spectrum of telomere disorders through a Registry which has been based at Johns Hopkins since 2005. Dr. Armanios is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Primary T Cell Immunodeficiency, Emphysema, and Ataxia-Telangiectasia. Dr. Armanios is board certified in American Board Of Internal Medicine.

Charlisa Gibson is an Intensive Care Medicine provider practicing medicine in Glen Burnie, Maryland. Dr. Gibson is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Pneumonia, Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastric Bypass, and Gastrostomy.

Elizabeth Mcilmoyle is an Intensive Care Medicine provider practicing medicine in Glen Burnie, Maryland. Dr. Mcilmoyle is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Obstructive Sleep Apnea.

Michael Downing is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Downing is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His clinical expertise encompasses Migraine with Brainstem Aura, Familial Hemiplegic Migraine, High Cholesterol, and Attention Deficit Hyperactivity Disorder (ADHD). Dr. Downing is currently accepting new patients.

John Wiley is an Intensive Care Medicine provider practicing medicine in Glen Burnie, Maryland. Dr. Wiley is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Pleurisy, Lung Nodules, and Lung Metastases.

Mark Brejt is a Radiologist practicing medicine in Glen Burnie, Maryland. Dr. Brejt is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. His clinical expertise encompasses Melorheostosis with Osteopoikilosis, Osteopenia, Melorheostosis, and Pleurisy.

Roman Culjat is a Pulmonary Medicine provider practicing medicine in Glen Burnie, Maryland. Dr. Culjat is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Drowsiness.

Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials. Dr. Bush is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pulmonary Fibrosis, Collapsed Lung, Lung Transplant, and Heart Transplant. Dr. Bush is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine.

David Kass is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Kass is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Hypertension, Pulmonary Fibrosis, and Heart Transplant.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Jeffrey Galvin is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Galvin is rated as an Advanced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Pneumomediastinum, and Interstitial Lung Disease.

Bradley Maron is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Maron is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Dr. Jonathan Orens is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He is an internationally recognized expert in lung transplantation. Dr. Orens received his M.D. from the University of Maryland School of Medicine. He completed his residency at the University of Maryland Medical Center and performed a fellowship in pulmonary and critical care medicine at the University of Michigan Hospitals. Dr. Orens joined the Johns Hopkins faculty in 1998. His research interests include clinical outcomes of lung transplantation, chronic allograft rejection and ischemic reperfusion injury. Dr. Orens is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Cystic Fibrosis, Secondary Immunodeficiency (SID), Lung Transplant, and Endoscopy. Dr. Orens is board certified in American Board Of Internal Medicine.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Transplant. Dr. Hassoun is board certified in American Board Of Internal Medicine.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Pulmonary Fibrosis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.